The apolipoprotein E epsilon 4 (APOE-4) is associated with a genetic vulnerability to Alzheimer's disease (AD) and with AD-related abnormalities in cortical rhythms. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.